Annual award announced for medical research charities wishing to benefit from artificial intelligence
BenevolentAI, in partnership with the Association of Medical Research Charities (“AMRC”) announced today it has created a new award, the BenevolentAI Award, to help charities accelerate their medical research and potentially develop new treatments and therapies using artificial intelligence.
The Award will be given to a single applicant once a year. BenevolentAI will offer the winning applicant access to the Company’s unique technology platform in order to solve specific research challenges the selected charity is facing. For example, to carry out deep investigation in a specific disease, create a better understanding of the disease, identify new areas and approaches in R&D and accelerate research towards new treatments and cures.
Applications for the Award open today. The deadline for submission is 31 January 2018. A winner will be announced at the AMRC & ABPI Patients First Conference on 20 March 2018.
Jackie Hunter, Head of Clinical Development at BenevolentAI commented:
“Most scientific breakthroughs are made by analysing data, but we live in a world where vast quantities of data make the discovery of new drugs and treatments for disease very difficult. We use AI to solve this issue and want to offer medical research charities the chance to benefit from the successes we have had as a company in developing, validating and commercialising this technology.”
Aisling Burnand, CEO of the AMRC, commented:
“Getting new treatments to people affected by life threatening and life limiting illnesses is of paramount importance to medical research charities. To do this we have to constantly embrace innovation, new ways of thinking, new ways of funding and use every tool in the box. Increasingly our members are recognising the vital role that advanced technologies can play in accelerating their work. The opportunity to have Benevolent AI work on a project for one of our members for a year is a very exciting prospect which could give that research process a huge kick start.”